14 October 2026
Site-specific glycosylation of oncogenic drivers using genetic code expansion.
16 September 2026
The European Proteomics Proteomics Association (EuPA), a federation of 23 European national societies for […]
7 September 2026
Mission: The project consists in analysing and dissecting the role of hyperglycosylation ofspecific surface […]
1 July 2026
Ferroptosis, a form of iron-dependent cell death, is attracting growing interest in cancer research. […]
31 March 2026
CRCM offers 31 PhD projects covering a wide range of topics in cancer research. These projects are proposed within the doctoral schools ED658 and ED659 and are accessible through their competitive selection process.
21 October 2025
CRCM welcomes a new team dedicated to the study of G protein-coupled receptors (GPCRs) […]
1 October 2025
Christophe Ginestier and his team are exploring a new therapeutic strategy to improve the management of relapsed patients.
24 September 2025
Anne-Sophie Chrétien, Frédéric Bard and Brice Chanez - all three recipients of specific "Pancreatic Cancer" funding from the ARC Foundation -.
10 February 2025
We are delighted to welcome Josephine Shabani, a Master 2 student at the University of Verona (Italy), who has recently joined our team.
10 February 2025
This publication in Cell reveals how two distinct E3 ligases target BACH1 quaternary degrons under oxidative stress, in collaboration with several research teams.
28 January 2025
Our research team has nurtured brilliant minds that have contributed to groundbreaking discoveries before embarking on exciting new paths.
28 January 2025
Dr Christophe Ginestier receives a €200,000 Pink Ribbon Award for his project on breast cancer treatment resistance, aimed at identifying new therapies to prevent recurrence.